These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 34010073)

  • 21. Two Multicenter, Randomized, Double-Blind, Parallel Group Comparison Studies of a Novel Foam Formulation of Halobetasol Propionate, 0.05% vs Its Vehicle in Adult Subjects With Plaque Psoriasis.
    Bhatia N; Stein Gold L; Kircik LH; Schreiber R
    J Drugs Dermatol; 2019 Aug; 18(8):790-796. PubMed ID: 31424709
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Development and Characterization of a Clobetasol Propionate Nanostructured Lipid Carrier-Based Gel for the Treatment of Plaque Psoriasis.
    Dadwal A; Mishra N; Narang RK
    Curr Mol Pharmacol; 2021; 14(3):399-411. PubMed ID: 32598275
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Increased bioavailability and improved efficacy, in severe psoriasis, of a new microemulsion formulation of cyclosporin.
    Gulliver WP; Murphy GF; Hannaford VA; Primmett DR
    Br J Dermatol; 1996 Sep; 135 Suppl 48():35-9. PubMed ID: 8881903
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clobetasol propionate lotion, an efficient and safe alternative to clobetasol propionate emollient cream in subjects with moderate to severe plaque-type psoriasis.
    Lowe N; Feldman SR; Sherer D; Weiss J; Shavin JS; Lin YL; Foley V; Soto P
    J Dermatolog Treat; 2005 Aug; 16(3):158-64. PubMed ID: 16096182
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neuroprotective effects of oleuropein: Recent developments and contemporary research.
    Butt MS; Tariq U; Iahtisham-Ul-Haq ; Naz A; Rizwan M
    J Food Biochem; 2021 Dec; 45(12):e13967. PubMed ID: 34716610
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Combining lesional short-contact dithranol therapy of psoriasis with a potent topical corticosteroid.
    Swinkels OQ; Prins M; Kucharekova M; de Boo T; Gerritsen MJ; van der Valk PG; van de Kerkhof PC
    Br J Dermatol; 2002 Apr; 146(4):621-6. PubMed ID: 11966693
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vivo Skin Penetration, Radical Protection, and Structural Changes after Topical Application of a Herbal Oil Cream Compared to Topical Calcipotriol in Mild to Moderate Psoriasis.
    Lademann J; Mansouri P; Nahavandi A; Ahlers A; Zibakalam-Mofrad F; Brower B; Nahavandi M; Feddern F; Darvin ME; Schanzer S; Richter H; Meinke MC; Rezaii SA; Rohaninasab M; Farshi S; Iacobelli M; Jung S
    Skin Pharmacol Physiol; 2021; 34(6):337-350. PubMed ID: 34404045
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cosm-nutraceutical nanovesicles for acne treatment: Physicochemical characterization and exploratory clinical experimentation.
    Amer SS; Nasr M; Abdel-Aziz RTA; Moftah NH; El Shaer A; Polycarpou E; Mamdouh W; Sammour O
    Int J Pharm; 2020 Mar; 577():119092. PubMed ID: 32004681
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy and Mechanisms of Oleuropein in Mitigating Diabetes and Diabetes Complications.
    Zheng S; Huang K; Tong T
    J Agric Food Chem; 2021 Jun; 69(22):6145-6155. PubMed ID: 34042426
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy, safety, and cost-effectiveness of all-trans retinoic acid/Clobetasol Propionate Compound Ointment in the treatment of mild to moderate psoriasis vulgaris: A randomized, single-blind, multicenter clinical trial.
    Xia L; Li R; Wang Y; Lin Z; Zheng J; Li X; Lu Q; Zhang J; Jin H; Fu L; Zhang X; Liu Y; Yang S; Xiao F; Gao XH
    Dermatol Ther; 2018 Sep; 31(5):e12632. PubMed ID: 30253049
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dithranol-loaded nanostructured lipid carrier-based gel ameliorate psoriasis in imiquimod-induced mice psoriatic plaque model.
    Sathe P; Saka R; Kommineni N; Raza K; Khan W
    Drug Dev Ind Pharm; 2019 May; 45(5):826-838. PubMed ID: 30764674
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Methotrexate-Loaded Nanostructured Lipid Carrier Gel Alleviates Imiquimod-Induced Psoriasis by Moderating Inflammation: Formulation, Optimization, Characterization, In-Vitro and In-Vivo Studies.
    Agrawal YO; Mahajan UB; Mahajan HS; Ojha S
    Int J Nanomedicine; 2020; 15():4763-4778. PubMed ID: 32753865
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Multi-component clobetasol-loaded monolithic lipid-polymer hybrid nanoparticles ameliorate imiquimod-induced psoriasis-like skin inflammation in Swiss albino mice.
    Pukale SS; Sharma S; Dalela M; Singh AK; Mohanty S; Mittal A; Chitkara D
    Acta Biomater; 2020 Oct; 115():393-409. PubMed ID: 32846238
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nanocarriers Mediated Topical Drug Delivery for Psoriasis Treatment.
    Gungor S; Rezigue M
    Curr Drug Metab; 2017; 18(5):454-468. PubMed ID: 28228078
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A novel nanogel formulation of methotrexate for topical treatment of psoriasis: optimization, in vitro and in vivo evaluation.
    Avasatthi V; Pawar H; Dora CP; Bansod P; Gill MS; Suresh S
    Pharm Dev Technol; 2016 Aug; 21(5):554-62. PubMed ID: 26024238
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A randomized study to evaluate the efficacy and safety of adding topical therapy to etanercept in patients with moderate to severe plaque psoriasis.
    Lebwohl MG; Kircik L; Callis Duffin K; Pariser D; Hooper M; Wenkert D; Thompson EH; Yang J; Kricorian G; Koo J
    J Am Acad Dermatol; 2013 Sep; 69(3):385-92. PubMed ID: 23643256
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy of the topical cyclosporine cream assisted by fractional carbon dioxide laser vs topical clobetasol cream for the treatment of plaque psoriasis: Randomized comparative study.
    Helmy A Y; El Batreek MH; Abdel Fadeel DA; Tawfik AA; Samy NA
    J Cosmet Dermatol; 2022 Aug; 21(8):3362-3370. PubMed ID: 34791789
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Self-assembled tacrolimus-loaded lecithin-chitosan hybrid nanoparticles for in vivo management of psoriasis.
    Fereig SA; El-Zaafarany GM; Arafa MG; Abdel-Mottaleb MMA
    Int J Pharm; 2021 Oct; 608():121114. PubMed ID: 34543618
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Assessing the Synergistic Effect of a Fixed Combination Halobetasol Propionate 0.01% and Tazarotene 0.045% Lotion in Moderate-to-Severe Plaque Psoriasis.
    Kircik LH; Papp KA; Stein Gold L; Harris S; Pharm TL; Pillai R
    J Drugs Dermatol; 2019 Mar; 18(3):279-284.. PubMed ID: 30909333
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The efficacy and tolerability of clobetasol propionate foam 0.05% in the treatment of mild to moderate plaque-type psoriasis of nonscalp regions.
    Gottlieb AB; Ford RO; Spellman MC
    J Cutan Med Surg; 2003; 7(3):185-92. PubMed ID: 12704534
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.